- Trials with a EudraCT protocol (275)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
275 result(s) found for: Turnover.
Displaying page 1 of 14.
EudraCT Number: 2019-003771-19 | Sponsor Protocol Number: 2019-100 | Start Date*: 2019-11-19 | |||||||||||
Sponsor Name:Aarhus Universitetshospital | |||||||||||||
Full Title: The effect of improved insulin sensitivity on bone turnover markers and bone biomechanical properties in persons with type 2 diabetes mellitus | |||||||||||||
Medical condition: Type 2 diabetes mellitus Diabetic bone disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-004316-73 | Sponsor Protocol Number: 3189 | Start Date*: 2006-08-23 |
Sponsor Name:Royal Liverpool University hospital | ||
Full Title: The effects of growth hormone, strontium ranelate and phosphate on PTH circadian rhythm, PTH target organ sensitivity, bone turnover markers, phospho-calcium metabolism and bone mineral density. A ... | ||
Medical condition: Osteoporosis and Reduced Bone mineral density (T scores< -1.0 on DEXA scan), Adult growth hormone deficiency ( GH levels,9mU/l on Insulin stress test) with reduced BMD (T scores< -1.0 on DEXA scan) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-004513-15 | Sponsor Protocol Number: | Start Date*: 2005-11-28 |
Sponsor Name:Univ. Prof. Dr. Christoph Zielinski | ||
Full Title: ASSESSMENT OF BIOCHEMICAL MARKERS OF BONE TURNOVER IN PATIENTS WITH METASTATIC BREAST CANCER SWITCHED FROM INTRAVENOUS ZOLEDRONIC ACID THERAPY TO ORAL IBANDRONATE | ||
Medical condition: Metastatic bone disease due to breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-010288-17 | Sponsor Protocol Number: 1516 | Start Date*: 2009-07-13 |
Sponsor Name:Karolinska Hospital | ||
Full Title: Breast cell turnover and mammographic density in women with Polycystic Ovary Syndrome (PCOS) | ||
Medical condition: Polycystic ovary syndrome (PCOS) is the most common hormonal aberration in women of fertile age, with a prevalence of 5-10%, and is associated with chronic anovulation, hyperandrogenism and PCO mo... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-021664-16 | Sponsor Protocol Number: SVUH | Start Date*: 2010-11-04 | |||||||||||
Sponsor Name:Solvotrin Innovations Ltd | |||||||||||||
Full Title: The role of doxycycline in the management of diastolic dysfunction | |||||||||||||
Medical condition: Diastolic dysfunction | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: Removed from public view |
EudraCT Number: 2020-005040-35 | Sponsor Protocol Number: 0120 | Start Date*: 2021-01-28 | |||||||||||
Sponsor Name:Aarhus University Hospital | |||||||||||||
Full Title: The effect of effervescent and buffered alendronate on bone turnover compared to conventional alendronate: A randomized non-inferiority trial | |||||||||||||
Medical condition: Osteopenia, i.e. bone mineral density T-score < -1 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-001041-17 | Sponsor Protocol Number: 20060289 | Start Date*: 2007-09-11 | |||||||||||
Sponsor Name:Amgen Inc. | |||||||||||||
Full Title: An Open Label, Single Arm, Extension Study to Evaluate the Long Term Safety and Sustained Efficacy of Denosumab (AMG162) in the Treatment of Postmenopausal Osteoporosis | |||||||||||||
Medical condition: Treatment of postmenopausal osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) SE (Completed) EE (Completed) DE (Completed) LV (Completed) GB (Completed) LT (Completed) HU (Completed) AT (Completed) FI (Completed) BE (Completed) MT (Completed) CZ (Completed) FR (Completed) ES (Completed) GR (Completed) IT (Completed) BG (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002975-17 | Sponsor Protocol Number: EMS/2004/017-04/33 | Start Date*: 2005-01-31 |
Sponsor Name:Epsom & St Helier University Hospitals NHS Trust | ||
Full Title: A pilot study to examine the effect of vitamin C on bone turnover and antioxidant levels in postmenopausal women with low bone density | ||
Medical condition: low bone density / osteoporosis postmenopausal women | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2006-006776-37 | Sponsor Protocol Number: Nij2007 | Start Date*: 2007-05-14 | |||||||||||
Sponsor Name:Radboud University Nijmegen Medical Center | |||||||||||||
Full Title: Towards the assessment of metabolic biomarkers and creatine uptake and turnover in skeletal muscles of patients with Facioscapulohumeral muscular dystrophy using MR spectroscopy | |||||||||||||
Medical condition: Healthy volunteers. Later the protocol will be applied to Facioscapular humeral dystrophy and/or other muscular dystrophies in general. | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006123-37 | Sponsor Protocol Number: SI-C-019 | Start Date*: 2012-06-06 | |||||||||||
Sponsor Name:Solvotrin Innovations Ltd | |||||||||||||
Full Title: Impact of Eplerenone on Asymptomatic Left Ventricular Diastolic Dysfunction in Diabetic Patients | |||||||||||||
Medical condition: Asymptomatic left ventricular diastolic dysfunction in diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003570-11 | Sponsor Protocol Number: BC-6072 | Start Date*: 2019-10-21 | |||||||||||
Sponsor Name:Ghent University Hospital | |||||||||||||
Full Title: The use of buffered soluble alendronate 70 mg (Steovess/Binosto) after denosumab discontinuation to prevent increase in bone turnover. | |||||||||||||
Medical condition: erosive osteoarthritis of the interphalangeal finger joints | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-001253-41 | Sponsor Protocol Number: GOIM16002-CABONESTUDY | Start Date*: 2018-03-12 | |||||||||||
Sponsor Name:GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE | |||||||||||||
Full Title: Impact of cabazitaxel on metastatic bone disease in patients with castration resistant prostate cancer previously treated with docetaxel | |||||||||||||
Medical condition: 1. Histologically or cytologically confirmed adenocarcinoma of prostate that is resistant to hormone therapy and previously treated with a docetaxel containing regimen. | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000178-24 | Sponsor Protocol Number: W2021.040 | Start Date*: 2023-10-20 |
Sponsor Name: | ||
Full Title: Active vitamin D for secondary hyperparathyroidism after bariatric surgery: a multicenter randomized controlled trial. | ||
Medical condition: patients with secondary hyperparathyroidism after Roux-en-Y gastric bypass surgery (RYGB). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2021-000275-36 | Sponsor Protocol Number: CSUB0202 | Start Date*: 2021-04-23 |
Sponsor Name:Sahlgrenska University Hospital | ||
Full Title: Prevention of Glucocorticoid induced impairment of bone metabolism – A Randomized, Placebo-Controlled, Single Centre Clinical Trial | ||
Medical condition: Oral glucocorticoid (GC) therapy leads to a rapid and profound effects on bone metabolism.The gut microbiota is involved in regulating bone metabolism.Lactobacillus reuteri (LR) has been shown to h... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016523-61 | Sponsor Protocol Number: PJMR0062105 | Start Date*: 2009-12-07 | |||||||||||
Sponsor Name:King’s College London [...] | |||||||||||||
Full Title: 18F-fluoride PET for Early Non-invasive Assessment of Cortical Bone Formation | |||||||||||||
Medical condition: Osteopenia Please note this is not a study to investigate the use of the IMP for the treatment of osteopenia but rather to validate a non-invasive imaging technique for measuring early changes in b... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003162-13 | Sponsor Protocol Number: WI232128 | Start Date*: 2019-01-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: A Study to investigate Bone turnover Markers in patients planned to receive tofacitinib | |||||||||||||
Medical condition: Rheumatoid arthritis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001481-18 | Sponsor Protocol Number: 6925 | Start Date*: 2011-10-07 |
Sponsor Name:Uppsala University Hospital | ||
Full Title: Uncemented total hip implant and subcutaneous injection of Denosumab for patients with osteoarthritis of the hip. A randomised double blind placebo controlled study on the effects on bone evaluated... | ||
Medical condition: Patients with osteoarthritis of the hip treated with an uncemented total hip arthroplasty. This procedure is accompanied with an increased risk for loss of bone adjacent to the implants | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002638-35 | Sponsor Protocol Number: 3.00 | Start Date*: 2012-07-31 |
Sponsor Name:Stockholms Läns Landsting, Karolinska Universitetssjukhuset Huddinge, Anestesikliniken | ||
Full Title: ALBUMIN KINETICS BY 123I-HSA A validation study on healthy volunteers, patients with acute inflammation, and patiens scheduled for major abdominal surgery | ||
Medical condition: A) healthy volunteers (transcapillary escape rate of albumin, plasmavolume, and turnover of albumin) B) Acute inflammation such as pancreatitis or cholecystitis C) Scheduled major abdominal surge... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002720-27 | Sponsor Protocol Number: 2014-002720-27 | Start Date*: 2014-12-04 |
Sponsor Name:Fundació Clínic per a la Recerca Biomèdica | ||
Full Title: Simplification from Tenofovir plus Lamivudine or Emtricitabine plus Ritonavir-Boosted-Protease Inhibitor to Ritonavir-Boosted-Atazanavir plus Lamivudine in Virologically-Suppressed-HIV-Infected Adu... | ||
Medical condition: Chronic HIV infection. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-003110-27 | Sponsor Protocol Number: 21.07.2016 | Start Date*: 2016-10-03 | |||||||||||
Sponsor Name:Bente Lomholt Langdahl, Dept. of Endocrinology and Internal Medicine, Aarhus University Hospital | |||||||||||||
Full Title: Bone turnover markers as predictors of treatment break outcome | |||||||||||||
Medical condition: Osteoporosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
